ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET

Rhea-AI Summary

ANI Pharmaceuticals, Inc. will release its fourth quarter and full year 2023 financial results on February 29, 2024. The conference call will be hosted by President and CEO Nikhil Lalwani and CFO Stephen P. Carey. The call will be available for replay on the company's website.

BAUDETTE, Minn., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, prior to the market open.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date		Thursday, February 29, 2024
Time		8:30 a.m. ET
Toll free (U.S.)		800-274-8461
Webcast (live and replay)		www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-839-8531 and entering access code 4470257.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

Investor Relations Contact:
Lisa M. Wilson, In-Site Communications, Inc.
212-452-2793
lwilson@insitecony.com

SOURCE: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals release its fourth quarter and full year 2023 financial results?

ANI Pharmaceuticals will release its fourth quarter and full year 2023 financial results on February 29, 2024.

Who will host the conference call to discuss the financial results?

The conference call will be hosted by President and CEO Nikhil Lalwani and CFO Stephen P. Carey.

Where can the replay of the conference call be accessed?

The replay of the conference call will be available on the company's website under the 'Investors' section.

How long will the replay of the conference call be accessible?

The replay of the conference call will be accessible for two weeks.